Veracyte (VCYT) Enterprise Value (2013 - 2026)

Veracyte has disclosed Enterprise Value across 14 years of filings, most recently posting $4.4 billion for Q2 2026.

• In Q2 2026, Enterprise Value rose 132.03% year-over-year to $4.4 billion; the TTM figure through Jun 2026 stood at $4.4 billion (up 132.03% YoY), while the FY2025 annual figure was $3.0 billion, up 4.85% from the prior year.
• Enterprise Value came in at $4.4 billion for Q2 2026 at Veracyte, up from $2.3 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $4.4 billion in Q2 2026 to a low of $1.0 billion in Q3 2022.
• Average Enterprise Value over 5 years is $2.0 billion, with a median of $1.8 billion recorded in 2022.
• Year-over-year, Enterprise Value slumped 67.44% in 2022 and jumped 132.03% in 2026.
• Over 5 years, Enterprise Value stood at $1.6 billion in 2022, then climbed by 15.82% to $1.8 billion in 2023, then jumped by 57.9% to $2.8 billion in 2024, then grew by 4.85% to $3.0 billion in 2025, then surged by 48.41% to $4.4 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $4.4 billion in Q2 2026, $2.3 billion in Q1 2026, and $3.0 billion in Q4 2025.